Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127717221 | 12771722 | 1 | I | 20160916 | 20160922 | 20160922 | EXP | ES-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00421 | SCIEGEN | CAMPOS DAVILA E ET AL.. RHABDOMYOLYSIS POSSIBLZ PROVOKED BY A SITAGLIPTINATORVASTATIN INTERACTION. EUROPEAN JOURNAL OF HOSPITAL PHARMACY - SCIENCE AND PRACTICE. 2014;21(1):145-146 | 80.00 | YR | M | Y | 0.00000 | 20160922 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127717221 | 12771722 | 1 | PS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Unknown | 40 MG, QD | Y | N | 205519 | 40 | MG | TABLET | |||||
| 127717221 | 12771722 | 2 | I | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Unknown | 80 MG, QD | Y | N | 205519 | 80 | MG | TABLET | |||||
| 127717221 | 12771722 | 3 | I | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Unknown | 40 MG, QD | Y | N | 205519 | 40 | MG | TABLET | |||||
| 127717221 | 12771722 | 4 | I | Sitagliptin | SITAGLIPTIN | 1 | Unknown | UNK | Y | 0 | |||||||||
| 127717221 | 12771722 | 5 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127717221 | 12771722 | 1 | Dyslipidaemia |
| 127717221 | 12771722 | 4 | Hyperglycaemia |
| 127717221 | 12771722 | 5 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127717221 | 12771722 | OT |
| 127717221 | 12771722 | LT |
| 127717221 | 12771722 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127717221 | 12771722 | Acute kidney injury | |
| 127717221 | 12771722 | Asthenia | |
| 127717221 | 12771722 | Blood calcium decreased | |
| 127717221 | 12771722 | Blood creatine phosphokinase increased | |
| 127717221 | 12771722 | Blood uric acid decreased | |
| 127717221 | 12771722 | Confusional state | |
| 127717221 | 12771722 | Drug interaction | |
| 127717221 | 12771722 | Hypomagnesaemia | |
| 127717221 | 12771722 | Muscle contractions involuntary | |
| 127717221 | 12771722 | Muscle spasms | |
| 127717221 | 12771722 | Myalgia | |
| 127717221 | 12771722 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |